Skip to main content
Erschienen in: Journal of General Internal Medicine 9/2018

18.07.2018 | Perspective

The Value of Outpatient Imaging-Based Cancer Screening Episodes

verfasst von: Joshua M. Liao, MD, MSc, Anirban Basu, PhD, Christoph I. Lee, MD, MS

Erschienen in: Journal of General Internal Medicine | Ausgabe 9/2018

Einloggen, um Zugang zu erhalten

Abstract

In order to shift US health care towards greater value, the Centers for Medicare & Medicaid Services (CMS) is exploring outpatient episode-based cost measures under the new Quality Payment Program and planning a bundled payment program that will introduce the first ever outpatient episodes of care. One novel approach to capitalize on this paradigm shift and extend bundled payment policies is to engage primary care physicians and specialists by bundling outpatient imaging studies and associated procedures—central tools in disease screening and diagnosis, but also tools that are expensive and susceptible to increasing health care costs and patient harm. For example, both breast and lung cancer screening represent target areas ripe for bundled payment given high associated costs and variation in management strategies and suboptimal care coordination between responsible clinicians. Benefits to imaging-based screening episodes include stronger alignment between providers (primary care physicians, radiologists, and other clinicians), reduction in unwarranted variation, creation of appropriateness standards, and ability to overcome barriers to cancer screening adherence. Implementation considerations include safeguarding against providers inappropriately withholding care as well as ensuring that accountability and financial risk are distributed appropriately among responsible clinicians.
Literatur
3.
Zurück zum Zitat Durand DJ, Lewin JS, Berkowitz SA. Medical-Imaging Stewardship in the Accountable Care Era. N Engl J Med. 2015; 373: 1691–1693.CrossRefPubMed Durand DJ, Lewin JS, Berkowitz SA. Medical-Imaging Stewardship in the Accountable Care Era. N Engl J Med. 2015; 373: 1691–1693.CrossRefPubMed
4.
Zurück zum Zitat Elmore JG, Gross CP. The cost of breast cancer screening in the United States: a picture is worth…a billion dollars? Ann Intern Med. 2014;160(3):203.CrossRefPubMed Elmore JG, Gross CP. The cost of breast cancer screening in the United States: a picture is worth…a billion dollars? Ann Intern Med. 2014;160(3):203.CrossRefPubMed
5.
Zurück zum Zitat Elmore JG, Wells CK, Lee CH, Howard DH, Feinstein AR. Variability in Radiologists’ Interpretations of Mammograms. N Engl J Med. 1994; 331:1493–1499.CrossRefPubMed Elmore JG, Wells CK, Lee CH, Howard DH, Feinstein AR. Variability in Radiologists’ Interpretations of Mammograms. N Engl J Med. 1994; 331:1493–1499.CrossRefPubMed
6.
Zurück zum Zitat Goulart BH, Bensink ME, Mummy DG, Ramsey SD. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost effectiveness.J Natl Comr Can Netw. 2012; 10)2): 267–275.CrossRef Goulart BH, Bensink ME, Mummy DG, Ramsey SD. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost effectiveness.J Natl Comr Can Netw. 2012; 10)2): 267–275.CrossRef
7.
Zurück zum Zitat Bach PB, Mirkin JN, Oliver TK, et al. Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review. JAMA. 2013; 307(22): 2418–2429.CrossRef Bach PB, Mirkin JN, Oliver TK, et al. Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review. JAMA. 2013; 307(22): 2418–2429.CrossRef
9.
Zurück zum Zitat Keating NL, Pace LE. Breast cancer screening in 2018: time for shared decision making. JAMA 2018; 319(17):1814–1815.CrossRefPubMed Keating NL, Pace LE. Breast cancer screening in 2018: time for shared decision making. JAMA 2018; 319(17):1814–1815.CrossRefPubMed
10.
Zurück zum Zitat Flowers CI, O’Donoghue C, Moore D, et al. Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat 2013; 139(3):769–777.CrossRefPubMedPubMedCentral Flowers CI, O’Donoghue C, Moore D, et al. Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat 2013; 139(3):769–777.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Liao JM, Emanuel EJ, Whittington GL, Small DS, Troxel AB, Zhu J, Zhong W, Navathe AS. Physician Practice Variation Under Orthopedic Bundled Payment. Am J Manag Care. 2018. (forthcoming). Liao JM, Emanuel EJ, Whittington GL, Small DS, Troxel AB, Zhu J, Zhong W, Navathe AS. Physician Practice Variation Under Orthopedic Bundled Payment. Am J Manag Care. 2018. (forthcoming).
12.
Zurück zum Zitat Liao JM, Hodlofski A, Whittington G, et al. Baptist Health System: Succeeding in Bundled Payments through Behavioral Principles. Healthcare (Amst). 2017; 5(3):136–140.CrossRef Liao JM, Hodlofski A, Whittington G, et al. Baptist Health System: Succeeding in Bundled Payments through Behavioral Principles. Healthcare (Amst). 2017; 5(3):136–140.CrossRef
13.
Zurück zum Zitat Lehman CD, Arao RF, Sprague BL, et al. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017; 283(1):59–69.CrossRefPubMedPubMedCentral Lehman CD, Arao RF, Sprague BL, et al. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017; 283(1):59–69.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hughes DR, Jiang M, McGinty G, Shetty, SK, Duszak, R. An empirical framework for breast screening bundled payments. J Am Coll Radiol. 2017; 14:17–23.CrossRefPubMed Hughes DR, Jiang M, McGinty G, Shetty, SK, Duszak, R. An empirical framework for breast screening bundled payments. J Am Coll Radiol. 2017; 14:17–23.CrossRefPubMed
16.
Zurück zum Zitat Powers BW, Navathe AS, Chaguturu SK, Ferris TG, Torchiana DF. Aligning incenties for value: The internal performance framework at Partners HealthCare. Healthc (Amst). 2017; 5(3): 141–149.CrossRefPubMed Powers BW, Navathe AS, Chaguturu SK, Ferris TG, Torchiana DF. Aligning incenties for value: The internal performance framework at Partners HealthCare. Healthc (Amst). 2017; 5(3): 141–149.CrossRefPubMed
Metadaten
Titel
The Value of Outpatient Imaging-Based Cancer Screening Episodes
verfasst von
Joshua M. Liao, MD, MSc
Anirban Basu, PhD
Christoph I. Lee, MD, MS
Publikationsdatum
18.07.2018
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe 9/2018
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4571-y

Weitere Artikel der Ausgabe 9/2018

Journal of General Internal Medicine 9/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.